Recombinant NAMPT antibody (AA 400-450)

Catalog No. ABIN7454014

The Rabbit Monoclonal anti-NAMPT antibody has been validated for WB, IHC, IP, ICC and FACS. It is suitable to detect NAMPT in samples from Human and Mouse.

Quick Overview for Recombinant NAMPT antibody (AA 400-450) (ABIN7454014)

Target: NAMPT (Nicotinamide phosphoribosyltransferase (NAMPT))

Antibody Type: Recombinant Antibody

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Monoclonal

Conjugate: This NAMPT antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC), Flow Cytometry (FACS)

Clone: BLR058F

Product Details anti-NAMPT Antibody

Binding Specificity: AA 400-450

Purpose: Rabbit anti-NAMPT/PBEF/Visfatin Recombinant Monoclonal Antibody [BLR058F]

Immunogen: between AA 400 and 450

Isotype: IgG

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Concentration: 1000 μg/mL

Buffer: Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Expiry Date: 12 months

Target Details for NAMPT

Target: NAMPT (Nicotinamide phosphoribosyltransferase (NAMPT))

Alternative Name: NAMPT/PBEF/Visfatin

Background: Background: PBEF is also known as visfatin and was first identified as a factor that enhanced the differentiation of B-cells. It is a secreted factor that is highly expressed in adipocytes. Intracellularly, PBEF acts as a cytosolic enzyme involved in nicotinamide adenine dinucleotide (NAD) synthesis. PBEF levels positively correlate with obesity and type 2 diabetes mellitus and can bind the insulin receptor to lower blood sugar.

Gene ID: 10135

NCBI Accession: NP_005737

UniProt: P43490